Atlas Trials

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1

Clinical trial NCT02485080 · WITHDRAWN

Trial details

NCT number
NCT02485080
Sponsor
Stanford University
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
PT-NANBH
Start date
2015-09-01
Primary completion
2016-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.